EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

CYP17A1 Genetic Polymorphisms Influencing Hyperandrogenism in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

Zelin Patarena Dawi Pramesti, Leny Silviana Farida, Sutrisno

ASIAN JOURNAL OF FERTILITY ENDOCRINOLOGY AND REPRODUCTION · 2026

DOI: 10.66060/ajfer.v1i3.31 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift ASIAN JOURNAL OF FERTILITY ENDOCRINOLOGY AND REPRODUCTION, 2026. Verfasst von Zelin Patarena Dawi Pramesti und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Polycystic ovary syndrome (PCOS) is a prevalent polygenic endocrine disorder affecting women during their reproductive years. It is marked by excessive androgen levels, irregular ovulation, and the presence of multiple ovarian follicles. The CYP17A1 gene has been implicated in androgen overproduction, yet the extent to which CYP17A1 genetic variants influence the susceptibility to PCOS is still uncertain. The following section summarizes studies that have examined the link between the CYP17A1 rs743572 polymorphism and PCOS risk in women of reproductive age.

Method

A thorough literature search was performed across three databases: SCOPUS, ScienceDirect, and PubMed, to identify studies meeting the inclusion criteria. The risk of bias for the included studies was evaluated using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist. Collected data were subsequently analyzed using RevMan version 5.4.

Result

Four studies involving 1,542 PCOS cases and 1,438 controls were included in the meta-analysis. CYP17A1 (rs743572) polymorphism was significantly associated with increased PCOS risk across all genetic models: allele model (OR = 1.39, 95% CI: 1.09-1.76, P = 0.007, I² = 51%), dominant model (OR = 1.53, 95% CI: 1.10-2.11, P = 0.01, I² = 43%), and recessive model (OR = 1.52, 95% CI: 1.10-2.10, P = 0.01, I² = 9%), indicating consistent positive associations with low to moderate heterogeneity.

Conclusion

The CYP17 T/C (rs74357) polymorphism is a significant factor contributing to heightened susceptibility to polycystic ovary syndrome in individuals carrying the C allele. These findings indicate that CYP17 gene polymorphisms could serve as a potential risk factor for developing polycystic ovary syndrome, or may play an important role in the associated metabolic and hormonal disorders

Zitieren

APA

Pramesti, Z. P. D., Farida, L. S., & Sutrisno (2026). CYP17A1 Genetic Polymorphisms Influencing Hyperandrogenism in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. ASIAN JOURNAL OF FERTILITY ENDOCRINOLOGY AND REPRODUCTION. https://doi.org/10.66060/ajfer.v1i3.31

Vancouver

Pramesti ZPD, Farida LS, Sutrisno. CYP17A1 Genetic Polymorphisms Influencing Hyperandrogenism in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. ASIAN JOURNAL OF FERTILITY ENDOCRINOLOGY AND REPRODUCTION. 2026. doi:10.66060/ajfer.v1i3.31

BibTeX
@article{Pramesti2026,
  author = {Pramesti, Zelin Patarena Dawi and Farida, Leny Silviana and Sutrisno},
  title = {CYP17A1 Genetic Polymorphisms Influencing Hyperandrogenism in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis},
  journal = {ASIAN JOURNAL OF FERTILITY ENDOCRINOLOGY AND REPRODUCTION},
  year = {2026},
  doi = {10.66060/ajfer.v1i3.31}
}
Kostenlos starten →